The use of synthetic control arms to evaluate patients with rare oncogene-driven subsets in NSCLC

Sanjay Popat, PhD, MBBS, FRCP, Royal Marsden NHSFT/BTOG Steering Committee, UK, discusses the use of real-world synthetic control arms to investigate rare oncogene-driven subsets in non-small cell lung cancer (NSCLC). This interview took place at the BTOG 2022 Summer Meeting congress in London.